Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours

NCT03852823 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumours
Cervical Cancer
Malignant Mesothelioma
Lymphoma
Non-Small-Cell Lung Cancer

Interventions

DRUG: SG001

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.